Toll-like receptor 2 senses hepatitis C virus core protein but not infectious viral particles

Journal of Innate Immunity

Volumn 1, Issue 5, 2009, Pages 446-454

  Hoffmann, Marco ^a   Zeisel, Mirjam B ^b,c   Jilg, Nikolaus ^a   Paranhos Baccalà, Glaucia ^d   Stoll Keller, Françoise ^b,c   Wakita, Takaji ^e   Hafkemeyer, Peter ^a   Blum, Hubert E ^a   Barth, Heidi ^a   Henneke, Philipp ^a   Baumert, Thomas F ^a,b,c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^c UNIVERSITÉ DE STRASBOURG   (France)

^d BIOMÉRIEUX   (France)

^e NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Core protein; Hepatitis C virus; Toll like receptors

Indexed keywords

CORE PROTEIN; HEPATITIS C VIRUS CORE PROTEIN; RECOMBINANT PROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL LINE; CELL SURFACE; CONTROLLED STUDY; EMBRYO; FEMALE; GENETIC TRANSFECTION; HEPATITIS C VIRUS; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INCUBATION TIME; INNATE IMMUNITY; MOLECULAR RECOGNITION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; VIRION; VIRUS CORE; VIRUS IMMUNITY; VIRUS PARTICLE;

ANIMALS; CELL LINE; CHO CELLS; CRICETINAE; CRICETULUS; HEPACIVIRUS; HUMANS; TOLL-LIKE RECEPTOR 2; VIRAL CORE PROTEINS; VIRION;

EID: 77953286248     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000226136     Document Type: Article

References (37)

1. Lindenbach BD, Thiel HJ, Rice CM: Flaviviridae: the viruses and their replication; in Knipe DM, Howley PM (eds): Fields Virology. Philadelphia, Lippincott-Raven, 2007, pp 1101-1152.
2. Akira S, Uematsu S, Takeuchi O: Pathogen recognition and innate immunity. Cell 2006;124:783-801.
3. Boehme KW, Compton T: Innate sensing of viruses by Toll-like receptors. J Virol 2004;78:7867-7873. (Pubitemid 38944272)
4. Machida K, Cheng KT, Sung VM, Levine AM, Foung S, Lai MM: Hepatitis C virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6. J Virol 2006;80:866-874. (Pubitemid 43062898)
5. Feldmann G, Nischalke HD, Nattermann J, Banas B, Berg T, Teschendorf C, Schmiegel W, Duhrsen U, Halangk J, Iwan A, Sauerbruch T, Caselmann WH, Spengler U: Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma. Clin Cancer Res 2006;12:4491-4498. (Pubitemid 44297797)
6. Dolganiuc A, Oak S, Kodys K, Golenbock DT, Finberg RW, Kurt-Jones E, Szabo G: Hepatitis C core and nonstructural 3 proteins trigger Toll-like receptor 2-mediated pathways and inflammatory activation. Gastroenterology 2004;127:1513-1524. (Pubitemid 39457776)
7. Dolganiuc A, Chang S, Kodys K, Mandrekar P, Bakis G, Cormier M, Szabo G: Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection. J Immunol 2006;177:6758-6768. (Pubitemid 44715040)
8. Baumert TF, Ito S, Wong DT, Liang TJ: Hepatitis C virus structural proteins assemble into viruslike particles in insect cells. J Virol 1998;72:3827-3836. (Pubitemid 28188682)
9. Barth H, Schnober EK, Neumann-Haefelin C, Thumann C, Zeisel MB, Diepolder HM, Hu Z, Liang TJ, Blum HE, Thimme R, Lambotin M, Baumert TF: Scavenger receptor class B is required for hepatitis C virus uptake and cross-presentation by human dendritic cells. J Virol 2008;82:3466-3479.
10. Bartosch B, Dubuisson J, Cosset FL: Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J Exp Med 2003;197:633-642. (Pubitemid 36314658)
11. Zeisel MB, Baumert TF: Production of infectious hepatitis C virus in tissue culture: a breakthrough for basic and applied research. J Hepatol 2006;44:436-439.
12. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z, Murthy K, Habermann A, Krausslich HG, Mizokami M, Bartenschlager R, Liang TJ: Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nature medicine 2005;11:791-796. (Pubitemid 41021213)
13. Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, Burton DR, Wieland SF, Uprichard SL, Wakita T, Chisari FV: Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci USA 2005;102:9294-9299. (Pubitemid 40923557)
14. Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, Liu CC, Maruyama T, Hynes RO, Burton DR, McKeating JA, Rice CM: Complete replication of hepatitis C virus in cell culture. Science 2005;309:623-626. (Pubitemid 41033648)
15. Rollier CS, Paranhos-Baccala G, Verschoor EJ, Verstrepen BE, Drexhage JA, Fagrouch Z, Berland JL, Komurian-Pradel F, Duverger B, Himoudi N, Staib C, Meyr M, Whelan M, Whelan JA, Adams VC, Larrea E, Riezu JI, Lasarte JJ, Bartosch B, Cosset FL, Spaan WJ, Diepolder HM, Pape GR, Sutter G, Inchauspe G, Heeney JL: Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicity. Hepatology 2007;45:602-613. (Pubitemid 46450611)
16. Barth H, Schnober EK, Zhang F, Linhardt RJ, Depla E, Boson B, Cosset FL, Patel AH, Blum HE, Baumert TF: Viral and cellular determinants of the hepatitis C virus envelope-heparan sulfate interaction. J Virol 2006;80:10579-10590. (Pubitemid 44628904)
17. Fang X, Zeisel MB, Wilpert J, Gissler B, Thimme R, Kreutz C, Maiwald T, Timmer J, Kern WV, Donauer J, Geyer M, Walz G, Depla E, von Weizsacker F, Blum HE, Baumert TF: Host cell responses induced by hepatitis C virus binding. Hepatology 2006;43:1326-1336. (Pubitemid 43980112)
18. Barth H, Ulsenheimer A, Pape GR, Diepolder HM, Hoffmann M, Neumann-Haefelin C, Thimme R, Henneke P, Klein R, Paranhos- Baccala G, Depla E, Liang TJ, Blum HE, Baumert TF: Uptake and presentation of hepatitis C virus-like particles by human dendritic cells. Blood 2005;105:3605-3614. (Pubitemid 40628207)
19. Heine H, Kirschning CJ, Lien E, Monks BG, Rothe M, Golenbock DT: Cutting edge: cells that carry a null allele for Toll-like receptor 2 are capable of responding to endotoxin. J Immunol 1999;162:6971-6975. (Pubitemid 29277661)
20. Lien E, Sellati TJ, Yoshimura A, Flo TH, Rawadi G, Finberg RW, Carroll JD, Espevik T, Ingalls RR, Radolf JD, Golenbock DT: Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J Biol Chem 1999;274:33419-33425. (Pubitemid 129511647)
21. Yoshimura A, Lien E, Ingalls RR, Tuomanen E, Dziarski R, Golenbock D: Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via toll-like receptor 2. J Immunol 1999;163:1-5. (Pubitemid 29295815)
22. Delude RL, Yoshimura A, Ingalls RR, Golenbock DT: Construction of a lipopolysaccharide reporter cell line and its use in identifying mutants defective in endotoxin, but not TNF-alpha, signal transduction. J Immunol 1998;161:3001-3009. (Pubitemid 28425725)
23. Medvedev AE, Henneke P, Schromm A, Lien E, Ingalls R, Fenton MJ, Golenbock DT, Vogel SN: Induction of tolerance to lipopolysaccharide and mycobacterial components in chinese hamster ovary/CD14 cells is not affected by overexpression of Toll-like receptors 2 or 4. J Immunol 2001;167:2257-2267. (Pubitemid 32747538)
24. Latz E, Visintin A, Lien E, Fitzgerald KA, Monks BG, Kurt-Jones EA, Golenbock DT, Espevik T: Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the toll-like receptor 4-md-2-cd14 complex in a process that is distinct from the initiation of signal transduction. J Biol Chem 2002;277:47834-47843. (Pubitemid 36159310)
25. Codran A, Royer C, Jaeck D, Bastien-Valle M, Baumert TF, Kieny MP, Pereira CA, Martin JP: Entry of hepatitis C virus pseudotypes into primary human hepatocytes by clathrin-dependent endocytosis. J Gen Virol 2006;87:2583-2593. (Pubitemid 44241234)
26. Blight KJ, McKeating JA, Rice CM: Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol 2002;76:13001-13014.
27. Kato T, Date T, Miyamoto M, Furusaka A, Tokushige K, Mizokami M, Wakita T: Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. Gastroenterology 2003;125:1808-1817. (Pubitemid 37500445)
28. Zeisel MB, Koutsoudakis G, Schnober EK, Haberstroh A, Blum HE, Cosset F-L, Wakita T, Jaeck D, Doffoel M, Royer C, Soulier E, Schvoerer E, Schuster C, Stoll-Keller F, Bartenschlager R, Pietschmann T, Barth H, Baumert TF: Scavenger receptor BI is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81. Hepatology 2007;46:1722-1731.
29. Maillard P, Krawczynski K, Nitkiewicz J, Bronnert C, Sidorkiewicz M, Gounon P, Dubuisson J, Faure G, Crainic R, Budkowska A: Nonenveloped nucleocapsids of hepatitis C virus in the serum of infected patients. J Virol 2001;75:8240-8250. (Pubitemid 32743696)
30. Pietschmann T, Kaul A, Koutsoudakis G, Shavinskaya A, Kallis S, Steinmann E, Abid K, Negro F, Dreux M, Cosset FL, Bartenschlager R: Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc Natl Acad Sci USA 2006;103:7408-7413. (Pubitemid 43727846)
31. Schuttler CG, Thomas C, Discher T, Friese G, Lohmeyer J, Schuster R, Schaefer S, Gerlich WH: Variable ratio of hepatitis C virus RNA to viral core antigen in patient sera. J Clin Microbiol 2004;42:1977-1981. (Pubitemid 38637810)
32. Tanaka E, Kiyosawa K, Matsumoto A, Kashiwakuma T, Hasegawa A, Mori H, Yanagihara O, Ohta Y: Serum levels of hepatitis C virus core protein in patients with chronic hepatitis C treated with interferon alfa. Hepatology 1996;23:1330-1333. (Pubitemid 26181212)
33. Nagao Y, Sata M, Itoh K, Tanikawa K, Kameyama T: Quantitative analysis of HCV RNA and genotype in patients with chronic hepatitis C accompanied by oral lichen planus. Eur J Clin Invest 1996;26:495-498. (Pubitemid 26226415)
34. Arase Y, Ikeda K, Chayama K, Murashima N, Tsubota A, Suzuki Y, Saitoh S, Kobayashi M, Kobayashi M, Suzuki F, Kumada H: Fluctuation patterns of HCV-RNA serum level in patients with chronic hepatitis C. J Gastroenterol 2000;35:221-225. (Pubitemid 30195635)
35. Gale M Jr, Foy EM: Evasion of intracellular host defence by hepatitis C virus. Nature 2005;436:939-945. (Pubitemid 41191669)
36. Saito T, Owen DM, Jiang F, Marcotrigiano J, Gale M: Innate immunity induced by composition- dependent RIG-I recognition of hepatitis C virus RNA. Nature 2008;454:523-527.
37. Kobayashi M, Yoshiki R, Sakabe J, Kabashima K, Nakamura M, Tokura Y: Expression of Toll-like receptor 2, NOD2 and dectin-1 and stimulatory effects of their ligands and histamine in normal human keratinocytes. Br J Dermatol 2009;160:297-304.